// you’re reading...

General Biotechnology

Merck: Successor pill safer than Vioxx

By Yali ⋅ October 14, 2004 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

Merck: Successor pill safer than Vioxx

Merck & Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the company�s planned successor pill, Arcoxia, is safer.

Print This Post

Discussion

No comments for “Merck: Successor pill safer than Vioxx”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com